Request for Covid-19 Impact Assessment of this Report
The United States Endometriosis Treatment Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Endometriosis Treatment Drugs market, reaching US$ million by the year 2028. As for the Europe Endometriosis Treatment Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Endometriosis Treatment Drugs players cover AbbVie Inc, Bayer AG, AstraZeneca, and Pfizer Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Endometriosis Treatment Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral Type
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
E-Commerce
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbbVie Inc
Bayer AG
AstraZeneca
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Ipsen Pharma
Myovant Sciences Ltd
Endoceutics, Inc
Debiopharm Group
Mayne Pharma Group
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Endometriosis Treatment Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Endometriosis Treatment Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Endometriosis Treatment Drugs by Country/Region, 2017, 2022 & 2028
2.2 Endometriosis Treatment Drugs Segment by Type
2.2.1 Oral Type
2.2.2 Others
2.3 Endometriosis Treatment Drugs Sales by Type
2.3.1 Global Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Endometriosis Treatment Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Endometriosis Treatment Drugs Sale Price by Type (2017-2022)
2.4 Endometriosis Treatment Drugs Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 E-Commerce
2.4.4 Others
2.5 Endometriosis Treatment Drugs Sales by Application
2.5.1 Global Endometriosis Treatment Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Endometriosis Treatment Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Endometriosis Treatment Drugs Sale Price by Application (2017-2022)
3 Global Endometriosis Treatment Drugs by Company
3.1 Global Endometriosis Treatment Drugs Breakdown Data by Company
3.1.1 Global Endometriosis Treatment Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Endometriosis Treatment Drugs Sales Market Share by Company (2020-2022)
3.2 Global Endometriosis Treatment Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Endometriosis Treatment Drugs Revenue by Company (2020-2022)
3.2.2 Global Endometriosis Treatment Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Endometriosis Treatment Drugs Sale Price by Company
3.4 Key Manufacturers Endometriosis Treatment Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Endometriosis Treatment Drugs Product Location Distribution
3.4.2 Players Endometriosis Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Endometriosis Treatment Drugs by Geographic Region
4.1 World Historic Endometriosis Treatment Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Endometriosis Treatment Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Endometriosis Treatment Drugs Annual Revenue by Geographic Region
4.2 World Historic Endometriosis Treatment Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Endometriosis Treatment Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Endometriosis Treatment Drugs Annual Revenue by Country/Region
4.3 Americas Endometriosis Treatment Drugs Sales Growth
4.4 APAC Endometriosis Treatment Drugs Sales Growth
4.5 Europe Endometriosis Treatment Drugs Sales Growth
4.6 Middle East & Africa Endometriosis Treatment Drugs Sales Growth
5 Americas
5.1 Americas Endometriosis Treatment Drugs Sales by Country
5.1.1 Americas Endometriosis Treatment Drugs Sales by Country (2017-2022)
5.1.2 Americas Endometriosis Treatment Drugs Revenue by Country (2017-2022)
5.2 Americas Endometriosis Treatment Drugs Sales by Type
5.3 Americas Endometriosis Treatment Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endometriosis Treatment Drugs Sales by Region
6.1.1 APAC Endometriosis Treatment Drugs Sales by Region (2017-2022)
6.1.2 APAC Endometriosis Treatment Drugs Revenue by Region (2017-2022)
6.2 APAC Endometriosis Treatment Drugs Sales by Type
6.3 APAC Endometriosis Treatment Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Endometriosis Treatment Drugs by Country
7.1.1 Europe Endometriosis Treatment Drugs Sales by Country (2017-2022)
7.1.2 Europe Endometriosis Treatment Drugs Revenue by Country (2017-2022)
7.2 Europe Endometriosis Treatment Drugs Sales by Type
7.3 Europe Endometriosis Treatment Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Endometriosis Treatment Drugs by Country
8.1.1 Middle East & Africa Endometriosis Treatment Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Endometriosis Treatment Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Endometriosis Treatment Drugs Sales by Type
8.3 Middle East & Africa Endometriosis Treatment Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Endometriosis Treatment Drugs
10.3 Manufacturing Process Analysis of Endometriosis Treatment Drugs
10.4 Industry Chain Structure of Endometriosis Treatment Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Endometriosis Treatment Drugs Distributors
11.3 Endometriosis Treatment Drugs Customer
12 World Forecast Review for Endometriosis Treatment Drugs by Geographic Region
12.1 Global Endometriosis Treatment Drugs Market Size Forecast by Region
12.1.1 Global Endometriosis Treatment Drugs Forecast by Region (2023-2028)
12.1.2 Global Endometriosis Treatment Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Endometriosis Treatment Drugs Forecast by Type
12.7 Global Endometriosis Treatment Drugs Forecast by Application
13 Key Players Analysis
13.1 AbbVie Inc
13.1.1 AbbVie Inc Company Information
13.1.2 AbbVie Inc Endometriosis Treatment Drugs Product Offered
13.1.3 AbbVie Inc Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Inc Main Business Overview
13.1.5 AbbVie Inc Latest Developments
13.2 Bayer AG
13.2.1 Bayer AG Company Information
13.2.2 Bayer AG Endometriosis Treatment Drugs Product Offered
13.2.3 Bayer AG Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bayer AG Main Business Overview
13.2.5 Bayer AG Latest Developments
13.3 AstraZeneca
13.3.1 AstraZeneca Company Information
13.3.2 AstraZeneca Endometriosis Treatment Drugs Product Offered
13.3.3 AstraZeneca Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AstraZeneca Main Business Overview
13.3.5 AstraZeneca Latest Developments
13.4 Pfizer Inc
13.4.1 Pfizer Inc Company Information
13.4.2 Pfizer Inc Endometriosis Treatment Drugs Product Offered
13.4.3 Pfizer Inc Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Inc Main Business Overview
13.4.5 Pfizer Inc Latest Developments
13.5 Teva Pharmaceutical Industries Ltd
13.5.1 Teva Pharmaceutical Industries Ltd Company Information
13.5.2 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Product Offered
13.5.3 Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.5.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.6 Ipsen Pharma
13.6.1 Ipsen Pharma Company Information
13.6.2 Ipsen Pharma Endometriosis Treatment Drugs Product Offered
13.6.3 Ipsen Pharma Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ipsen Pharma Main Business Overview
13.6.5 Ipsen Pharma Latest Developments
13.7 Myovant Sciences Ltd
13.7.1 Myovant Sciences Ltd Company Information
13.7.2 Myovant Sciences Ltd Endometriosis Treatment Drugs Product Offered
13.7.3 Myovant Sciences Ltd Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Myovant Sciences Ltd Main Business Overview
13.7.5 Myovant Sciences Ltd Latest Developments
13.8 Endoceutics, Inc
13.8.1 Endoceutics, Inc Company Information
13.8.2 Endoceutics, Inc Endometriosis Treatment Drugs Product Offered
13.8.3 Endoceutics, Inc Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Endoceutics, Inc Main Business Overview
13.8.5 Endoceutics, Inc Latest Developments
13.9 Debiopharm Group
13.9.1 Debiopharm Group Company Information
13.9.2 Debiopharm Group Endometriosis Treatment Drugs Product Offered
13.9.3 Debiopharm Group Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Debiopharm Group Main Business Overview
13.9.5 Debiopharm Group Latest Developments
13.10 Mayne Pharma Group
13.10.1 Mayne Pharma Group Company Information
13.10.2 Mayne Pharma Group Endometriosis Treatment Drugs Product Offered
13.10.3 Mayne Pharma Group Endometriosis Treatment Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Mayne Pharma Group Main Business Overview
13.10.5 Mayne Pharma Group Latest Developments
14 Research Findings and Conclusion
Table 1. Endometriosis Treatment Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Endometriosis Treatment Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral Type
Table 4. Major Players of Others
Table 5. Global Endometriosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Endometriosis Treatment Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Endometriosis Treatment Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Endometriosis Treatment Drugs Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Endometriosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Endometriosis Treatment Drugs Revenue by Application (2017-2022)
Table 13. Global Endometriosis Treatment Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Endometriosis Treatment Drugs Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Endometriosis Treatment Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Endometriosis Treatment Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Endometriosis Treatment Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Endometriosis Treatment Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Endometriosis Treatment Drugs Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Endometriosis Treatment Drugs Producing Area Distribution and Sales Area
Table 21. Players Endometriosis Treatment Drugs Products Offered
Table 22. Endometriosis Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Endometriosis Treatment Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Endometriosis Treatment Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Endometriosis Treatment Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Endometriosis Treatment Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Endometriosis Treatment Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Endometriosis Treatment Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Endometriosis Treatment Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Endometriosis Treatment Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Endometriosis Treatment Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Endometriosis Treatment Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Endometriosis Treatment Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Endometriosis Treatment Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Endometriosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Endometriosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Endometriosis Treatment Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Endometriosis Treatment Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Endometriosis Treatment Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Endometriosis Treatment Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Endometriosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Endometriosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Endometriosis Treatment Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Endometriosis Treatment Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Endometriosis Treatment Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Endometriosis Treatment Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Endometriosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Endometriosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Endometriosis Treatment Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Endometriosis Treatment Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Endometriosis Treatment Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Endometriosis Treatment Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Endometriosis Treatment Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Endometriosis Treatment Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Endometriosis Treatment Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Endometriosis Treatment Drugs
Table 66. Key Market Challenges & Risks of Endometriosis Treatment Drugs
Table 67. Key Industry Trends of Endometriosis Treatment Drugs
Table 68. Endometriosis Treatment Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Endometriosis Treatment Drugs Distributors List
Table 71. Endometriosis Treatment Drugs Customer List
Table 72. Global Endometriosis Treatment Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Endometriosis Treatment Drugs Sales Market Forecast by Region
Table 74. Global Endometriosis Treatment Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Endometriosis Treatment Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Endometriosis Treatment Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Endometriosis Treatment Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Endometriosis Treatment Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Endometriosis Treatment Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Endometriosis Treatment Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Endometriosis Treatment Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Endometriosis Treatment Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Endometriosis Treatment Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Endometriosis Treatment Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Endometriosis Treatment Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Endometriosis Treatment Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Endometriosis Treatment Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Endometriosis Treatment Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Endometriosis Treatment Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Endometriosis Treatment Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Endometriosis Treatment Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. AbbVie Inc Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. AbbVie Inc Endometriosis Treatment Drugs Product Offered
Table 94. AbbVie Inc Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. AbbVie Inc Main Business
Table 96. AbbVie Inc Latest Developments
Table 97. Bayer AG Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Bayer AG Endometriosis Treatment Drugs Product Offered
Table 99. Bayer AG Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Bayer AG Main Business
Table 101. Bayer AG Latest Developments
Table 102. AstraZeneca Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. AstraZeneca Endometriosis Treatment Drugs Product Offered
Table 104. AstraZeneca Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. AstraZeneca Main Business
Table 106. AstraZeneca Latest Developments
Table 107. Pfizer Inc Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer Inc Endometriosis Treatment Drugs Product Offered
Table 109. Pfizer Inc Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Pfizer Inc Main Business
Table 111. Pfizer Inc Latest Developments
Table 112. Teva Pharmaceutical Industries Ltd Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Product Offered
Table 114. Teva Pharmaceutical Industries Ltd Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Teva Pharmaceutical Industries Ltd Main Business
Table 116. Teva Pharmaceutical Industries Ltd Latest Developments
Table 117. Ipsen Pharma Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. Ipsen Pharma Endometriosis Treatment Drugs Product Offered
Table 119. Ipsen Pharma Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Ipsen Pharma Main Business
Table 121. Ipsen Pharma Latest Developments
Table 122. Myovant Sciences Ltd Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Myovant Sciences Ltd Endometriosis Treatment Drugs Product Offered
Table 124. Myovant Sciences Ltd Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Myovant Sciences Ltd Main Business
Table 126. Myovant Sciences Ltd Latest Developments
Table 127. Endoceutics, Inc Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Endoceutics, Inc Endometriosis Treatment Drugs Product Offered
Table 129. Endoceutics, Inc Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Endoceutics, Inc Main Business
Table 131. Endoceutics, Inc Latest Developments
Table 132. Debiopharm Group Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Debiopharm Group Endometriosis Treatment Drugs Product Offered
Table 134. Debiopharm Group Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Debiopharm Group Main Business
Table 136. Debiopharm Group Latest Developments
Table 137. Mayne Pharma Group Basic Information, Endometriosis Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Mayne Pharma Group Endometriosis Treatment Drugs Product Offered
Table 139. Mayne Pharma Group Endometriosis Treatment Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Mayne Pharma Group Main Business
Table 141. Mayne Pharma Group Latest Developments
List of Figures
Figure 1. Picture of Endometriosis Treatment Drugs
Figure 2. Endometriosis Treatment Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Endometriosis Treatment Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Endometriosis Treatment Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Endometriosis Treatment Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral Type
Figure 10. Product Picture of Others
Figure 11. Global Endometriosis Treatment Drugs Sales Market Share by Type in 2021
Figure 12. Global Endometriosis Treatment Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Endometriosis Treatment Drugs Consumed in Hospital Pharmacies
Figure 14. Global Endometriosis Treatment Drugs Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 15. Endometriosis Treatment Drugs Consumed in Retail Pharmacies
Figure 16. Global Endometriosis Treatment Drugs Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 17. Endometriosis Treatment Drugs Consumed in E-Commerce
Figure 18. Global Endometriosis Treatment Drugs Market: E-Commerce (2017-2022) & (K Units)
Figure 19. Endometriosis Treatment Drugs Consumed in Others
Figure 20. Global Endometriosis Treatment Drugs Market: Others (2017-2022) & (K Units)
Figure 21. Global Endometriosis Treatment Drugs Sales Market Share by Application (2017-2022)
Figure 22. Global Endometriosis Treatment Drugs Revenue Market Share by Application in 2021
Figure 23. Endometriosis Treatment Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Endometriosis Treatment Drugs Revenue Market Share by Company in 2021
Figure 25. Global Endometriosis Treatment Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Endometriosis Treatment Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global Endometriosis Treatment Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global Endometriosis Treatment Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas Endometriosis Treatment Drugs Sales 2017-2022 (K Units)
Figure 30. Americas Endometriosis Treatment Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC Endometriosis Treatment Drugs Sales 2017-2022 (K Units)
Figure 32. APAC Endometriosis Treatment Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe Endometriosis Treatment Drugs Sales 2017-2022 (K Units)
Figure 34. Europe Endometriosis Treatment Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Endometriosis Treatment Drugs Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Endometriosis Treatment Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas Endometriosis Treatment Drugs Sales Market Share by Country in 2021
Figure 38. Americas Endometriosis Treatment Drugs Revenue Market Share by Country in 2021
Figure 39. United States Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Endometriosis Treatment Drugs Sales Market Share by Region in 2021
Figure 44. APAC Endometriosis Treatment Drugs Revenue Market Share by Regions in 2021
Figure 45. China Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Endometriosis Treatment Drugs Sales Market Share by Country in 2021
Figure 52. Europe Endometriosis Treatment Drugs Revenue Market Share by Country in 2021
Figure 53. Germany Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Endometriosis Treatment Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Endometriosis Treatment Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Endometriosis Treatment Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Endometriosis Treatment Drugs in 2021
Figure 66. Manufacturing Process Analysis of Endometriosis Treatment Drugs
Figure 67. Industry Chain Structure of Endometriosis Treatment Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...